This study aimed to investigate comparative clinical courses for a series of women with amniotic fluid embolism (AFE) and to assess factors associated with patient survival. Clinical courses of nine patients with AFE in a single tertiary centre were reviewed. AFE was diagnosed when a woman presented with typical clinical symptoms accompanied by abnormal laboratory tests (including abnormal coagulation) or at autopsy when fetal debris was found in the maternal pulmonary arteries. Five patients survived and four died. The first clinical manifestations of AFE were variable; dyspnoea was noted in only four patients. Other signs were state of shock, abdominal pain and uterine atony. The mean ± SD interval between the onset of clinical manifestations and treatment was significantly shorter for survivors (48.0 ± 36.3 min) than for non-survivors (137.5 ± 49.7 min). The number of failed organs was significantly fewer for the survivors compared with the nonsurvivors. AFE was accompanied by a wide variety of clinical manifestations, but early diagnosis and treatment appeared to be the most critical factors associated with survival.
Introduction
Amniotic fluid embolism (AFE) is a rare obstetric syndrome in pregnant women that results in acute circulatory failure and disseminated intra-vascular coagulation (DIC). 1 It occurs in an estimated 1 out of 8000 -80 000 births, 2 and the mortality rate is extremely high, at > 80%. 3 The clinical presentation is characteristically abrupt and unexpected, characterized by dyspnoea, cyanosis and hypotension, but can be variable.
The present study was designed to review the comparative clinical course among a series of nine women with AFE who were admitted to a single tertiary centre and to assess factors associated with survival.
Patients and methods PATIENTS
This observational study involved the review of the clinical records for nine patients with Y Matsuda, M Kamitomo Clinical course of amniotic fluid embolism AFE who were admitted to the Kagoshima City Hospital, Kagoshima, Japan, from 1989 to 2000. The Institutional Review Board of Kagoshima City Hospital approved the study protocol and verbal informed consent was obtained from all participants. AFE was diagnosed when a woman presented with typical clinical symptoms accompanied by abnormal laboratory tests, including abnormal coagulation study results, or at autopsy when fetal debris was found in maternal pulmonary arteries. 4
STATISTICAL ANALYSIS
Statistical analyses were carried out using the SPSS ® statistical package, version 12.0 (SPSS Inc., Chicago, IL, USA) for Windows ® , and were performed using the Mann-Whitney U-test, χ 2 test and Fisher's exact probability test. A P-value < 0.05 was considered to be statistically significant.
Results

CLINICAL OVERVIEW OF PATIENTS
The clinical profiles and characteristics of the nine patients are shown in Table 1 . Mean ± SD gestational age was 38.9 ± 1.5 weeks, mean maternal age was 28.4 ± 7.1 years and mean maternal parity was 0.6 ± 0.7 for the nine patients. Three patients (patients 4, 5 and 6) gave birth at the Kagoshima City Hospital. The remaining six patients (patients 1, 2, 3, 7, 8 and 9) were referred to the Kagoshima City Hospital from other hospitals or antenatal clinics. Five patients survived (patients 1 -5), while the remaining four patients died (patients 6 -9), resulting in a mortality rate of 44.4%. Of the four patients who died, three were 'dead on arrival' (DOA) from the referral hospital/clinic (patients 7, 8 and 9). Patients 7 and 9 were diagnosed with AFE based on the detection of fetal debris in maternal pulmonary arteries at autopsy. The other seven (patients 1, 2, 3, 4, 5, 6 and 8) were diagnosed with AFE based on their clinical course along with abnormal laboratory findings. In these patients, high levels of zinc coproporphyrin I (> 35 nmol/l), which is a characteristic component of meconium and has been reported to be useful for diagnosing AFE, were detected in maternal plasma. 5, 6 Risk factors for AFE associated with the patients were variable. Thick meconium staining of the amniotic fluid was found in five patients. Other risk factors included uterine rupture, lower uterine segment laceration during the course of vaginal birth after a previous caesarean section, nonreassuring fetal status, oxytocin administration, hypertonic uterus and vacuum delivery. None of the women in this study had a history of allergy.
Patient 4 was diagnosed with AFE during the intra-partum period whilst the other patients were diagnosed during the postpartum period, mainly soon after delivery. The clinical course for each patient before treatment is summarized below. All fetuses survived, except for the one born to patient 7.
The first clinical manifestations observed in this series of women with AFE were cyanosis, dyspnoea, chest pain, hypotension, state of shock, abdominal pain and uterine atony ( Table 1) .
The presence of coagulopathy was assessed in seven patients (patients 1, 2, 3, 4, 5, 6 and 9). Six patients (patients 1, 3, 4, 5, 6 and 9) had fibrinogen levels < 100 mg/dl and prothrombin times that were abnormal. Antithrombin-III levels of < 60 mg/dl were found in three patients (patients 1, 3 and 6), and platelet counts were < 100 000/ml in three patients (patients 2, 5 and 9).
The mean interval from AFE symptom onset to treatment for the group of survivors was significantly shorter than for the group of non-survivors (P = 0.032). The mean number of failed organs was also significantly fewer for the survivors compared with the non-survivors (P = 0.031). These patients were treated and managed intensively, which included treatment with packed red blood cells, fresh frozen plasma, platelets and antithrombin-III concentrate.
EACH PATIENT'S PRE-TREATMENT CLINICAL COURSE
Patient 1
This patient was a 24-year-old pregnant woman who had been diagnosed with preeclampsia at another hospital. Her blood pressure was 145/95 mmHg and proteinurea was positive at 39 weeks of gestation when she was hospitalized for rupture of the membrane. Thick meconium staining of the amniotic fluid was found. Emergency caesarean section was performed due to nonreassuring fetal status. During surgery, she complained of dyspnoea that resembled an asthma attack. In spite of the administration of theophylline and steroids, her general condition worsened. Severe dyspnoea continued after surgery, whereupon she was transferred to the Kagoshima City Hospital.
Patient 2
This patient was a 35-year old pregnant woman who had undergone a caesarean section 3 years earlier for a previous delivery. At 39 weeks of gestation, at another hospital, she received oxytocin and prostaglandin to induce labour for a vaginal delivery. After vacuum delivery, vaginal laceration was noted and repaired. Abnormal genital bleeding and lower abdominal pain continued. Uterine rupture was diagnosed by vaginal examination. Emergency surgery was performed and the ruptured portion of the uterus was repaired. She was transferred to the Kagoshima City Hospital because of persistent dyspnoea, chest pain and cyanosis.
Patient 3
At another hospital, this 27-year old pregnant woman delivered a baby by vacuum extraction at 37 weeks of gestation. Genital bleeding persisted, the uterus did not contract sufficiently and total blood loss exceeded 3000 ml. She was transferred to the Kagoshima City Hospital because she entered a state of shock. The initial diagnosis was uterine atony.
Patient 4
This patient was a 40-year old pregnant woman who was admitted to the Kagoshima City Hospital due to the onset of labour. Acute and severe uterine contractions occurred immediately after spontaneous rupture of the membrane. Because fetal bradycardia occurred simultaneously, emergency caesarean section was performed at 40 weeks of gestation. After delivery of the fetus and placenta, the uterus did not contract sufficiently and total blood loss exceeded 2000 ml. A diagnosis of uterine atony was made and a hysterectomy was performed. Although abruption placentae was strongly suspected in this patient, retroplacental haematoma was not found.
Patient 5
This patient was a 16-year old pregnant woman who was admitted to the Kagoshima City Hospital due to the onset of labour at 37 weeks of gestation. Uterine hypertonic contractions were noted. After acute progressive delivery, she complained of abdominal pain and dyspnoea, and was in a state of shock. Uterine contractions were very weak and abnormal genital bleeding persisted. No cervical or perineal lacerations were detected.
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Patient 6
At 34 weeks of gestation, this 29-year old pregnant woman was admitted to the Kagoshima City Hospital for pre-eclampsia and twin pregnancy. Maternal blood pressure was 140/90 mmHg and proteinurea was positive. At 37 weeks of gestation, the first twin was delivered by spontaneous vaginal delivery, while the second twin was delivered by caesarean section due to prolonged deceleration. Three hours after the surgery, maternal blood pressure began to decrease. She tended to lose consciousness and to be cyanotic. Because abdominal distension continued, transabdominal puncture was performed. Bloody ascites was found. Emergent re-operation was performed with a hysterectomy because of severe uterine atony.
Patient 7
This patient was a 27-year old pregnant woman who delivered a baby at a private midwife's home at 40 weeks of gestation. The midwife transferred the baby to the Kagoshima City Hospital due to severe neonatal asphyxia. When she returned to her home clinic, the mother was in a state of shock. Abnormal genital bleeding persisted, the patient went deeper into shock and, as a result, was returned to Kagoshima City Hospital. She was pronounced DOA.
Patient 8
At another hospital, this 33-year old pregnant woman received oxytocin and prostaglandin to induce labour at 41 weeks of gestation. A caesarean section was performed because of poor progress of labour. Meconium staining of amniotic fluid was found. Six hours after surgery, the patient was in shock and complained of chest pain. As hypotension persisted, she was transferred to Kagoshima City Hospital but was pronounced DOA.
Patient 9
At another hospital, this 26-year old pregnant woman received oxytocin to induce labour at 40 weeks of gestation. Thick meconium staining of amniotic fluid was found. After vacuum delivery she complained of dyspnoea. She was transferred to Kagoshima City Hospital, but was pronounced DOA.
Discussion
Classically, the diagnosis of AFE was made at autopsy, with the demonstration of squamous cells or debris in the maternal pulmonary artery vasculature. 7 Subsequently, however, it has been demonstrated that squamous cells and other debris of presumed fetal origin might be found in blood aspirated from the central venous or pulmonary artery circulation of living patients with AFE. 8 The detection of squamous cells in the pulmonary artery circulation is not, however, pathognomotic for AFE, as some amniotic fluid may routinely enter the venous circulation of pregnant women. 4, 9 Originally, AFE was characterized by hypoxia, hypotension or haemodynamic collapse and coagulopathy. 10 The diagnosis of AFE must be made principally on the basis of clinical presentation and supportive laboratory studies and after excluding, with reasonable certainty, any other diagnosis such as septic shock, aspiration pneumonia, acute myocardial infarction, air embolism, pulmonary thromboembolism, cerebrovascular accident, eclampsia, anaphylaxis or coagulopathy associated with placental abruption. 11, 12 In the present series, these symptoms were not present in any patient.
In the UK, since 1962 both suspected and confirmed cases have been included in the AFE category. 13 The criteria of the national register for suspected AFE in the UK are (i) Y Matsuda, M Kamitomo Clinical course of amniotic fluid embolism acute hypotension or cardiac arrest, (ii) acute hypoxia, or (iii) coagulopathy, or (iv) a combination of all of these symptoms, occurring during labour or caesarean delivery or within 30 min of delivery with no other explanation for the findings. In the present study, each patient fulfilled one or more of these criteria. We believe, therefore, that the diagnostic criteria used in the present study were reasonable. A new registration procedure for AFE in Japan, including the results of this study, is now being established.
The mortality rate of 44.4% (4/9) in the current patient series was lower than previously reported rates (61 -80%). 3 Gilbert and Danielsen, 14 however, reported a much decreased mortality (26.4%) in a populationbased study and speculated that this was the result of developments in intensive care and a multidisciplinary approach to the treatment of AFE.
In the series of women with AFE in the present study, meconium-stained amniotic fluid and uterine atony were observed in five and four patients, respectively. Phillips and Davidson 15 concluded that the amount of procoagulant in the meconium-stained amniotic fluid was sufficient to cause significant intravascular coagulation. Tissue factor, a primary biological initiator of coagulation, is found in increasing amounts in amniotic fluid as gestation increases. Lockwood et al. 16 postulated that the large quantities of active tissue factor in amniotic fluid could explain the changes in coagulation accompanying AFE. Thrombin may stimulate secretion of vascular endothelin. Animal studies have shown that this vasoactive peptide can depress both myometrial and myocardial contractility. This, in turn, can contribute to both the haemodynamic changes and uterine atony frequently observed in AFE. 17 DIC-type postpartum haemorrhage without laceration of the birth canal appears to be a variant form of AFE without acute-phase symptoms. 18 In the concept of the anaphylactoid syndrome of pregnancy, which was renamed by Dildy and Clark, 10 it is important to emphasize that the clinical findings are secondary to biochemical mediator levels, rather than pulmonary embolic phenomena. In addition to typical symptoms, physicians should be aware of, and carefully determine the presence of, atypical symptoms of AFE such as uterine atony or unexplained cardiorespiratory failure in the peripartum period. 19 Benson 20 proposed the classification of AFE as type 1 AFE syndrome with DIC (laboratory or clinical) and type 2 AFE syndrome without DIC. Identifying these clinical signs in the early stage of the disease process may contribute to an improvement in the survival rate of patients with AFE. A high level of suspicion for the disorder should, therefore, be maintained in order to facilitate early recognition and treatment of patients with AFE. 21 
